Foundation for Influenza Epidemiology

The Foundation for Influenza Epidemiology was created by Sanofi Pasteur to formalize several years of commitment to epidemiological research on severe influenza

[Foundation for Influenza Epidemiology @GIHSN_Project]

Thank you all for your participation in the #GIHSN Annual Meeting in Paris ! A committed community of investigators from 23 countries generating data on severe #influenza cases and the circulation of #virus. With representatives from @WHO, the US CDC, the Chinese CDC, #GISAID

[Foundation for Influenza Epidemiology @GIHSN_Project]

Global Influenza Hospital Surveillance Network - GIHSN Annual Meeting Webinar 19-20 October 2020. Join us to discuss flu surveillance & Covid impact. With site investigators from 23 countries, flu experts & international health authorities. #WHO #GISAID https://t.co/IpXVxhcc80

[GISAID Initiative @GISAID]

In a silver lining to this historic public health crisis, researchers from 117 nations have shared via GISAID #coronavirus genomes and associated data from 100,000 cases of #COVID-19. Effective Collaboration @WHO @DrTedros @CDCgov @CEPIvaccines @gavi @wef

[Foundation for Influenza Epidemiology @GIHSN_Project]

Launch of the GIHSN Call for Proposal for the 2020-21 Flu season. The GIHSN is a worldwide platform to generate timely and high-quality epidemiological data and virological information on severe influenza. Interested in joining? Apply here👉
https://t.co/vCkk47Itfp

[Foundation for Influenza Epidemiology @GIHSN_Project]

The GIHSN, a global platform generating epidemiological data on patients hospitalized with acute respiratory illness in 23 countries, can be used for severe COVID-19 surveillance and research. Contact us if you want to partner.
https://t.co/3tRh05VNks

[The IFA @IFAgeing]

Tomorrow IFA and @IFPMA will hold a Network Meeting to better understand how to improve #influenza vaccination rates. Organizations in attendance include @WHO @GIHSN_Project @sanofipasteur @medwma @worldheartfed @ZNConsulting @ChathamHouse @FIP_org

[Tedros Adhanom Ghebreyesus @DrTedros]

Building on experience and systems already in place for related pathogens, @WHO has activated global networks of experts, quickly developed advice for countries everywhere, and is working with them to activate their response systems. #coronavirus

[Foundation for Influenza Epidemiology @GIHSN_Project]

The new nearest bat precursor sequence (96% identical) found by Zhengli Shi's lab is now publicly accessible via #GISAID. The first US cas is in #GISAID too. @WHO

[Soumya Swaminathan @doctorsoumya]

The new nearest bat precursor sequence (96% identical) found by Zhengli Shi's lab is now publicly accessible via #GISAID. The first US case is in #GISAID too. @DrTedros @DrMikeRyan @WHO @JeremyFarrar @CDCgov

[Foundation for Influenza Epidemiology @GIHSN_Project]

The Foundation for Influenza #Epidemiology is evolving towards the development of capacities to link clinical and virological #data in #Influenza positive patients. Explanations with Pr Bruno Lina, Chair of the Scientific Committee of the Foundation

#realworldevidence #vaccines

[Área de Investigación en Vacunas @AIVFisabio]

Ayer el #AIV participó en la 7a Reunión Anual de la red @GIHSN_Project en la que se decidió el objetivo para la próxima temporada de #gripe: caracterizar los casos más graves mediante la secuenciación del virus. @ainara_mira presentó nuestros últimos resultados

[Foundation for Influenza Epidemiology @GIHSN_Project]

Poster session on-going at the #GIHSN 7th Annual Meeting : Investigators from the 5 continents are presenting the results of the 2018-2019 epidemic season #RealWorldEvidence #vaccines #AnnualMeetingGIHSN @OPENHEALTH_Co

[Foundation for Influenza Epidemiology @GIHSN_Project]

Start of the #GIHSN round table on the #flu strain selection process : Dr Wenqing Zhang, @WHO, Pr John McClauley, The Crick Institute, Dr Peter Bogner, GISAID and Pr Bruno Lina, Lyon NIC are discussing the current & future challenges of the #strain selection process

[Área de Investigación en Vacunas @AIVFisabio]

Un estudio del #AIV para la #GIHSN revela que:

1⃣Ni siquiera las personas #jóvenes y sanas se libran de ser hospitalizadas por #gripe
2⃣Las #mujeres #embarazadas se encuentran entre los grupos más vulnerables

Texto completo aquí: https://t.co/J5xK2ABj5a

[Ainara Mira Iglesias @ainara_mira]

Resultados publicados de la temporada gripal 2015/2016 en la red #Global #Influenza #Hospital #Surveillance #Network #GIHSN Estudio llevado a cabo por el #AIV de @GVAfisabio con datos de 11 países.

[Área de Investigación en Vacunas @AIVFisabio]

Noticia | #VAHNSI es miembro de una red mucho más amplia de recogida de datos llamada #GIHSN (Global Influenza Hospital Surveillance Network). En la que participan más de 15 países en el mundo. Consulta su web aquí: https://t.co/8x63TqG5AT #AIV

[Área de Investigación en Vacunas @AIVFisabio]

Nuevo mes y nuevo calendario de actividades. En octubre:
3-5/ Congreso @AEV_Vacunas
7-8/ Visita de seguimiento de la @WHO para el proyecto #GVSMCC
13-15/ Reunión de la #GIHSN
16/ Reunión inicio ensayo #VIGIRA de @SaludISCIII
17/ Congreso Nacional @rvbiobancos #iCONSENT

[Foundation for Influenza Epidemiology @GIHSN_Project]

Start of the #GIHSN round table on the #flu strain selection process : Dr Wenqing Zhang, @WHO, Pr John McClauley, The Crick Institute, Dr Peter Bogner, GISAID and Pr Bruno Lina, Lyon NIC are discussing the current & future challenges of the #strain selection process

[Foundation for Influenza Epidemiology @GIHSN_Project]

Poster session on-going at the #GIHSN 7th Annual Meeting : Investigators from the 5 continents are presenting the results of the 2018-2019 epidemic season #RealWorldEvidence #vaccines #AnnualMeetingGIHSN @OPENHEALTH_Co

[Foundation for Influenza Epidemiology @GIHSN_Project]

The GIHSN 7th Annual Meeting just started in Paris ! 55 participants from 26 countries, with @WHO as observer, are ready to discuss severe #influenza cases worldwide, linking #virological and clinical information.
@OPENHEALTH_Co #RealWorldEvidence #Vaccines

[OPENHEALTH_Co @OPENHEALTH_Co]

C'est parti pour l'Annual Meeting du @GIHSN_Project, plateforme internationale de génération de données sur la grippe sévère !
55 participants de 26 pays, avec the @WHO pour 2 jours d'échange sur la grippe et la vaccination.
#GIHSN #RealWorldEvidence #Vaccines